What does MOMS mean in RESEARCH
Management of Myelomeningocele Study (MOMS) is a comprehensive research program that investigates the long-term outcomes and effectiveness of various treatment strategies for myelomeningocele (MMC), a birth defect involving the incomplete closure of the spinal cord and its protective membranes.
MOMS meaning in Research in Academic & Science
MOMS mostly used in an acronym Research in Category Academic & Science that means Management of myelomeningocele study
Shorthand: MOMS,
Full Form: Management of myelomeningocele study
For more information of "Management of myelomeningocele study", see the section below.
MOMS
MOMS is a collaborative effort involving multiple research centers across the United States. The study was initiated in 1988 and has followed over 400 children with MMC for over 30 years.
Research Objectives
MOMS aims to:
- Determine the optimal timing and technique for surgical closure of the MMC defect
- Evaluate the effectiveness of different surgical approaches, including open surgery and fetoscopic surgery
- Assess the long-term neurological, developmental, and functional outcomes of children with MMC
- Identify factors that influence outcomes and improve the quality of life for these individuals
Study Methods
MOMS participants were randomized to receive either early or delayed surgical closure of their MMC defect. They underwent regular follow-up examinations to assess their health, neurological function, cognitive development, and quality of life.
Key Findings
The MOMS study has provided valuable insights into the management of MMC, including:
- Early surgical closure of the MMC defect is associated with better neurological outcomes
- Fetoscopic surgery may be an effective alternative to open surgery in selected cases
- Children with MMC experience a range of developmental and functional challenges, requiring comprehensive medical and rehabilitative care
Essential Questions and Answers on Management of myelomeningocele study in "SCIENCE»RESEARCH"
What is the Management of Myelomeningocele Study (MOMS)?
MOMS is a large-scale research study that aims to investigate the long-term effects of different surgical approaches for treating myelomeningocele, a birth defect that affects the spinal cord. The study is funded by the National Institutes of Health (NIH) and is conducted by a team of researchers from multiple medical centers across the United States.
What are the goals of the MOMS study?
The primary goal of MOMS is to determine which surgical approach is most effective in improving the long-term outcomes of children with myelomeningocele. The study will also examine the impact of surgery on the development of other health conditions, such as hydrocephalus and cognitive impairment.
Who is eligible to participate in the MOMS study?
Children with myelomeningocele who are less than 1 year old are eligible to participate in the study. The study is enrolling participants at multiple medical centers across the United States.
What are the different surgical approaches that are being studied in the MOMS study?
The MOMS study is comparing two different surgical approaches for treating myelomeningocele: open fetal surgery and postnatal repair. Open fetal surgery is performed before the baby is born, while postnatal repair is performed after birth.
What are the potential benefits of participating in the MOMS study?
Participants in the MOMS study will have access to the latest treatments for myelomeningocele and will be closely monitored by a team of experts. The study will also provide valuable information about the long-term effects of myelomeningocele and the effectiveness of different surgical approaches.
What are the potential risks of participating in the MOMS study?
The potential risks of participating in the MOMS study include the risks associated with surgery and the risks associated with the research procedures. The study team will discuss the risks and benefits of participation with potential participants before they enroll in the study.
Final Words: MOMS is a landmark study that has significantly advanced our understanding of MMC and its management. The findings from MOMS have informed clinical practice guidelines and treatment strategies, improving the outcomes and quality of life for individuals with this birth defect.
MOMS also stands for: |
|
| All stands for MOMS |